Gain insights into bioscience, technology and the quest to improve human health.
A trivalent flu vaccine outperforms a monovalent one produced by the same manufacturer, in part by triggering early interferon responses in the blood, according to Jackson Laboratory researchers and their collaborators.
Supplemental Material offers a behind-the-scenes look into research happening at JAX.
Learn about new technologies and therapies from people on the front lines of discovery.
Navigate through an A-to-Z listing of the latest topical content in your area of interest.